Cargando…
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associat...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892166/ https://www.ncbi.nlm.nih.gov/pubmed/36370291 http://dx.doi.org/10.1007/s10875-022-01366-7 |
_version_ | 1784881290385817600 |
---|---|
author | Aschenbrenner, Dominik Ye, Ziqing Zhou, Ying Hu, Wenhui Brooks, Isabel Williams, Isabelle Capitani, Melania Gartner, Lisa Kotlarz, Daniel Snapper, Scott B. Klein, Christoph Muise, Aleixo M. Marsden, Brian D. Huang, Ying Uhlig, Holm H. |
author_facet | Aschenbrenner, Dominik Ye, Ziqing Zhou, Ying Hu, Wenhui Brooks, Isabel Williams, Isabelle Capitani, Melania Gartner, Lisa Kotlarz, Daniel Snapper, Scott B. Klein, Christoph Muise, Aleixo M. Marsden, Brian D. Huang, Ying Uhlig, Holm H. |
author_sort | Aschenbrenner, Dominik |
collection | PubMed |
description | Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associated with monogenic inflammatory bowel disease. We identify 36 non-synonymous and non-sense variants in the IL10RA gene. Since the majority of these IL10RA variants have not been functionally characterized, we performed a systematic screening of their impact on STAT3 phosphorylation upon IL-10 stimulation. Based on the geographic accumulation of confirmed pathogenic IL10RA variants in East Asia and in Northeast China, the distribution of infectious disorders worldwide, and the functional evidence of IL-10 signaling in the pathogenesis, we identify Schistosoma japonicum infection as plausible selection pressure driving variation in IL10RA. Consistent with this is a partially augmented IL-10 response in peripheral blood mononuclear cells from heterozygous variant carriers. A parasite-driven heterozygote advantage through reduced IL-10 signaling has implications for health care utilization in regions with high allele frequencies and potentially indicates pathogen eradication strategies that target IL-10 signaling. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01366-7. |
format | Online Article Text |
id | pubmed-9892166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-98921662023-02-03 Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications Aschenbrenner, Dominik Ye, Ziqing Zhou, Ying Hu, Wenhui Brooks, Isabel Williams, Isabelle Capitani, Melania Gartner, Lisa Kotlarz, Daniel Snapper, Scott B. Klein, Christoph Muise, Aleixo M. Marsden, Brian D. Huang, Ying Uhlig, Holm H. J Clin Immunol Original Article Balancing natural selection is a process by which genetic variants arise in populations that are beneficial to heterozygous carriers, but pathogenic when homozygous. We systematically investigated the prevalence, structural, and functional consequences of pathogenic IL10RA variants that are associated with monogenic inflammatory bowel disease. We identify 36 non-synonymous and non-sense variants in the IL10RA gene. Since the majority of these IL10RA variants have not been functionally characterized, we performed a systematic screening of their impact on STAT3 phosphorylation upon IL-10 stimulation. Based on the geographic accumulation of confirmed pathogenic IL10RA variants in East Asia and in Northeast China, the distribution of infectious disorders worldwide, and the functional evidence of IL-10 signaling in the pathogenesis, we identify Schistosoma japonicum infection as plausible selection pressure driving variation in IL10RA. Consistent with this is a partially augmented IL-10 response in peripheral blood mononuclear cells from heterozygous variant carriers. A parasite-driven heterozygote advantage through reduced IL-10 signaling has implications for health care utilization in regions with high allele frequencies and potentially indicates pathogen eradication strategies that target IL-10 signaling. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01366-7. Springer US 2022-11-12 2023 /pmc/articles/PMC9892166/ /pubmed/36370291 http://dx.doi.org/10.1007/s10875-022-01366-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Aschenbrenner, Dominik Ye, Ziqing Zhou, Ying Hu, Wenhui Brooks, Isabel Williams, Isabelle Capitani, Melania Gartner, Lisa Kotlarz, Daniel Snapper, Scott B. Klein, Christoph Muise, Aleixo M. Marsden, Brian D. Huang, Ying Uhlig, Holm H. Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title | Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title_full | Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title_fullStr | Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title_full_unstemmed | Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title_short | Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications |
title_sort | pathogenic interleukin-10 receptor alpha variants in humans — balancing natural selection and clinical implications |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892166/ https://www.ncbi.nlm.nih.gov/pubmed/36370291 http://dx.doi.org/10.1007/s10875-022-01366-7 |
work_keys_str_mv | AT aschenbrennerdominik pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT yeziqing pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT zhouying pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT huwenhui pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT brooksisabel pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT williamsisabelle pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT capitanimelania pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT gartnerlisa pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT kotlarzdaniel pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT snapperscottb pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT kleinchristoph pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT muisealeixom pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT marsdenbriand pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT huangying pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications AT uhligholmh pathogenicinterleukin10receptoralphavariantsinhumansbalancingnaturalselectionandclinicalimplications |